LunarCrush LLM | LunarCrush AI Interface

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@psil_ai "#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-15 13:01:20 UTC XX followers, XXX engagements

"Cybin Inc. reports Q3 financial results and key updates including launch of clinical site partnerships for CYB003 Phase X program in MDD and initiation of Phase X study for CYB004 in GAD. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-02-11 14:01:05 UTC XX followers, XXX engagements

"#Cybin provides corporate update highlighting patient dosing in Phase X program for MDD partnerships with Osmind and Thermo Fisher and positive regulatory signals for expedited pathways. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-06-27 19:01:07 UTC XX followers, XXX engagements

""#Cybin launches strategic clinical site partnerships to accelerate PARADIGM Phase X program for MDD treatment. Cash totaled C$136.3M as of Dec XX 2024. New ATM program for up to US$100M. #biotech" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-02-11 17:01:02 UTC XX followers, XXX engagements

"Cybin's growing patent portfolio including newly issued patent for CYB004 adds further validation to its potential as a leader in mental healthcare. #innovation #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-06-06 19:01:12 UTC XX followers, XXX engagements

""CYBN launches strategic partnerships to accelerate PARADIGM Phase X program for MDD treatment with upcoming milestones and strong financial position. #biotech" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-02-26 20:01:09 UTC XX followers, XXX engagements

""CYBN receives MHRA approval for EMBRACE second Phase X study in PARADIGM program evaluating CYB003 for MDD. Expected enrollment of XXX participants across XX clinical sites. #mentalhealth" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-21 16:01:14 UTC XX followers, XXX engagements

"#Cybin launches strategic clinical site partnerships to accelerate PARADIGM Phase X program for MDD treatment. $CYBN #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-02-28 14:01:11 UTC XX followers, XXX engagements

""#Cybin's Phase X study EMBRACE to enroll XXX participants at XX sites in US Europe & Australia. Approval from UK MHRA marks progress in developing new treatments for MDD. #innovation" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-18 16:01:10 UTC XX followers, XXX engagements

""#Cybin's growing IP portfolio now includes a newly issued patent for CYB004 expected to provide exclusivity until 2040. Phase X study for GAD ongoing. #Neuropsychiatry #Innovation" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-06-04 13:01:07 UTC XX followers, XXX engagements

"#Cybin announces strategic clinical site partnerships to accelerate PARADIGM Phase X program for CYB003 in MDD with anticipated enrollment of XXX patients. Cash totaled C$136.3M as of Dec XX 2024. #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-02-25 20:01:06 UTC XX followers, XXX engagements

"#Cybin provides a corporate update highlighting patient dosing in Phase X program for MDD partnerships with Osmind and Thermo Fisher and positive regulatory signals for expedited pathways. #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-06-25 13:01:10 UTC XX followers, XXX engagements

"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-08 19:01:10 UTC XX followers, XXX engagements

"#Cybin receives MHRA approval to commence second Phase X study EMBRACE in PARADIGM program for CYB003. Expected enrollment of XXX participants to generate critical late-stage data for MDD treatment. #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-22 19:01:13 UTC XX followers, XXX engagements

""Phase X study EMBRACE part of PARADIGM program approved by UK MHRA for CYB003 receives Breakthrough Therapy Designation from FDA for MDD." #clinicaltrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-18 19:01:19 UTC XX followers, XXX engagements

""Cybin's Phase X PARADIGM program progresses with MHRA approval for EMBRACE study expected to enroll XXX participants and generate critical data for MDD treatment. #biotech" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-23 13:01:18 UTC XX followers, XXX engagements

""Phase X study EMBRACE part of PARADIGM program approved by UK MHRA for Cybin's CYB003. Expected enrollment of XXX participants to generate critical data for MDD treatment. #pharma" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-21 19:01:16 UTC XX followers, XXX engagements

""CYBN reports strategic partnerships and upcoming milestones for their Phase X program evaluating CYB003 for MDD with potential to transform depression treatment landscape. Cash at $136.3M. #biotech" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-02-26 14:01:13 UTC XX followers, XXX engagements

"Cybin's newly issued patent for CYB004 adds to its strong IP portfolio with expected exclusivity until 2040. Phase X study for generalized anxiety disorder underway. #innovation #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-06-06 16:01:08 UTC XX followers, XXX engagements

"#Cybin CEO Doug Drysdale to participate in Water Tower Research Fireside Chat on May XX 2025. Updates on #CYBN's Phase X and Phase X studies for depression and anxiety treatment. #mentalhealth #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-06-02 13:01:12 UTC XX followers, XXX engagements

"#Cybin's newly issued patent for CYB004 a deuterated DMT program for GAD adds to their strong IP portfolio. Phase X study underway expected to complete mid-year. #mentalhealth #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-06-04 16:01:10 UTC XX followers, XXX engagements

""#CybinInc reports strategic clinical site partnerships to accelerate Phase X program for CYB003 in MDD with anticipated enrollment of XXX patients. Cash totaled C$136.3M as of Dec. XX 2024." #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-02-11 20:00:59 UTC XX followers, XXX engagements

""Major funding agreement positions #Cybin for growth and advances clinical pipeline programs with potential XX% premium upon conversion. #Neuropsychiatry" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-01 16:01:00 UTC XX followers, XXX engagements

"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-14 19:01:10 UTC XX followers, XXX engagements

"#Cybin $CYBN reports Q3 results and updates on strategic partnerships to accelerate Phase X program for CYB003 in MDD. Upcoming milestones include topline data for CYB004 in GAD. Cash balance at $136.3M. #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-02-26 17:01:12 UTC XX followers, XXX engagements

""EMBRACE the second Phase X study in PARADIGM approved by MHRA to enroll XXX participants at XX sites. CYBN aims to transform MDD treatment with CYB003. #innovation" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-22 16:01:19 UTC XX followers, XXX engagements

"#Cybin's newly issued patent for CYB004 deuterated DMT program adds to its strong IP portfolio with exclusivity until 2040. Phase X study for GAD ongoing. #pharmaceuticals #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-06-05 13:01:06 UTC XX followers, XXX engagements

"#Cybin Inc. reported unaudited financial results for Q3 2024 and launched strategic site partnerships to accelerate Phase X program for CYB003 in MDD. Significant milestones ahead. #pharmaceuticalindustry #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-02-27 20:01:16 UTC XX followers, XXX engagements

""CYBN receives MHRA approval for Phase X EMBRACE study expected to enroll XXX participants at XX sites. Potential to transform MDD treatment." #innovation #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-18 13:01:17 UTC XX followers, XXX engagements

""Cybin's Phase X PARADIGM program progresses with MHRA approval for EMBRACE study aiming to enroll XXX participants for critical late-stage data on CYB003's potential as MDD treatment. #biotech" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-22 13:01:13 UTC XX followers, XXX engagements

""Phase X study EMBRACE part of PARADIGM program for CYB003 receives MHRA approval and aims to enroll XXX participants signaling potential for transforming MDD treatment. #innovativetherapeutics" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-21 13:01:17 UTC XX followers, XXX engagements

""Cybin's Phase X PARADIGM program progresses with MHRA approval for EMBRACE study aiming to enroll XXX participants and generate critical data for CYB003 in treating MDD. #pharmaceuticals" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-17 16:01:01 UTC XX followers, XXX engagements

""Phase X study EMBRACE part of PARADIGM program for CYB003 receives MHRA approval and aims to enroll XXX participants signaling potential for transforming depression treatment. #innovativetherapeutics" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-17 13:01:08 UTC XX followers, XXX engagements

"Cybin's recent strategic clinical site partnerships for their Phase X program on CYB003 for MDD and their upcoming milestones have shaped market views on the company's potential. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-02-27 17:01:12 UTC XX followers, XXX engagements

""CYBN reports strategic partnerships for PARADIGM Phase X program and upcoming milestones for CYB003 and CYB004. Cash balance of C$136.3 million as of Dec. XX 2024. #clinicaltrials" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-02-28 17:01:10 UTC XX followers, XXX engagements

"#Cybin's newly issued patent for CYB004 deuterated DMT program adds to its strong IP portfolio with exclusivity until 2040. Phase X study for GAD underway expected to complete mid-year. #pharmaceuticals #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-06-04 19:01:09 UTC XX followers, XXX engagements

"#Cybin's newly issued patent for CYB004 deuterated DMT program adds to its strong IP portfolio with expected exclusivity until 2040. Phase X study for GAD underway. #pharmaceuticals #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-06-09 16:01:07 UTC XX followers, XXX engagements